ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

HBx promotes hepatocellular carcinoma progression by repressing the transcription level of miR-187-5p

Deng, Yang; Wang, La; Zhang, Yingjie; Sun, Dandan; Min, Hang; Zhou, Hao; Xu, Chengchen; Xu, Na; Qiu, Fengwu; Zhou, Jingjiao; Zhou, Junwuhan univ sci & technol; wuhan blood ctr
Aging-US2023-8-15
1被引11阅读
引用收藏
分享

摘要

HBV-associated hepatitis B virus x protein (HBx) plays multiple roles in the development of hepatocellular carcinoma. In our prior study, we discovered that miR-187-5p expression was inhibited by HBx. To investigate the underlying molecular mechanism of HBx-mediated miR-187-5p downregulation in hepatocellular carcinoma cells, effects of HBx and miR-187-5p on hepatoma carcinoma cell were observed, as well as their interactions. Through in vitro and in vivo experiments, we demonstrated that overexpression of miR-187-5p inhibited proliferation, migration, and invasion. Simultaneously, we observed a dysregulation in the expression of miR187-5p in liver cancer cell lines, which may be attributed to transcriptional inhibition through the E2F1/FoxP3 axis. Additionally, we noted that HBx protein is capable of enhancing the expression of E2F1, a transcription factor that promotes the expression of FoxP3. In conclusion, our results suggest that the inhibitory effect of HBx on miR-187-5p is mediated through the E2F1/FoxP3 axis. As shown in this work, HBx promotes hepatoma carcinoma cell proliferation, migration, and invasion through the E2F1/FoxP3/miR-187 axis. It provides a theoretical basis for finding therapeutic targets that will help clinic treatment for HCC.

学科与关键词

关键词
hepatocellular carcinomaHBxmiR-187-5p
相关
加载中…
  • 乙型肝炎病毒X蛋白通过靶向miR-200c诱导DNA异常甲基化
    张媛悦; 王淑青; 刘岩; 刘艳坤; 李玉辉; 李玉凤PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 1-11.
  • miRNA-518a-3p Inhibits Hepatocarcinogenesis by Down-Regulating ZNF281
    Chen, Diandian; Shi, Kezhi*; Hu, Yili*JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37(8): 4377-4385.
  • Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma
    Qin, Shijie; Xu, Jieyun; Yi, Yunmeng; Jiang, Sizhu; Jin, Ping*; Xia, Xinyi*; Ma, Fei*Frontiers in Oncology, 2021, 11: 691115.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Aging-US
发表日期
2023-08-15
卷期
第 15 卷, 第 15 期
页码
7533-7550
语言
ENGLISH
成果收录
SCIE
资助标注
14th Five Year Plan Hubei Provincial advantaged characteristics disciplines (groups) project of Wuhan University of Science and Technology [2023C0303]; 2020 Hubei provincial key research and development Plan [:2020BCB048]

作者

  • D

    Deng, Yang (第一作者)

    wuhan univ sci & technol

  • W

    Wang, La

    wuhan univ sci & technol

查看全部 11 位作者收起作者
  • Z

    Zhang, Yingjie

    wuhan univ sci & technol

  • S

    Sun, Dandan

    wuhan univ sci & technol

  • M

    Min, Hang

    wuhan univ sci & technol

  • Z

    Zhou, Hao

    wuhan univ sci & technol

  • X

    Xu, Chengchen

    wuhan univ sci & technol

  • X

    Xu, Na

    wuhan univ sci & technol

  • Q

    Qiu, Fengwu

    wuhan blood ctr

  • Z

    Zhou, Jingjiao

  • Z

    Zhou, Jun

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417